Ji, Yuting – Trademark Portfolio

Entity Type: 01

Ji, Yuting holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include BGRY. The owner is based in Fuzhou, Fujian.

2002 - 82 Wusi Rd, Rongdu Building

Fuzhou, Fujian 350001 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BGRY
BGRY
Registered 2025
IIMII
IIMII
Cancelled 2018
SAGETEC
SAGETEC
Abandoned 2017

Trademark Classifications

Ji, Yuting's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Ji, Yuting have?

Ji, Yuting has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 1 cancelled.

What trademark classes does Ji, Yuting file in?

Ji, Yuting files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Ji, Yuting's most well-known trademarks?

Ji, Yuting's registered trademark portfolio includes well-known marks such as BGRY. These are among 1 currently registered trademark in the portfolio.

What is Ji, Yuting's trademark registration success rate?

Ji, Yuting has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.